Case Report: A Drug Database Model as a Central Element for Computer-Supported Dose Adjustment within a CPOE System. - Peter Martin; Walter E. Haefeli; Meret Martin-Facklam (J. Am. Medical Informatics Assoc., 2004)

Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans. - Dean F. Wong; Susanne Ostrowitzki; Yun Zhou 006; Vanessa Raymont; Carsten Hofmann; Edilio Borroni; Anil Kumar; Nikhat Parkar; James R. Brasic; John Hilton; Robert F. Dannals; Meret Martin-Facklam (NeuroImage, 2013)

Human Activity Recognition from Sensor-Based Large-Scale Continuous Monitoring of Parkinson's Disease Patients. - Wei-Yi Cheng; Alf Scotland; Florian Lipsmeier; Timothy Kilchenmann; Liping Jin; Jens Schjodt-Eriksen; Detlef Wolf; Yan-Ping Zhang Schärer; Ignacio Fernández García; Juliane Siebourg-Polster; Jay Soto; Lynne Verselis; et al. (CHASE, 2017)

Large-Scale Continuous Mobility Monitoring of Parkinson's Disease Patients Using Smartphones. - Wei-Yi Cheng; Florian Lipsmeier; Andrew Creigh; Alf Scotland; Timothy Kilchenmann; Liping Jin; Jens Schjodt-Eriksen; Detlef Wolf; Yan-Ping Zhang Schärer; Ignacio Fernández García; Juliane Siebourg-Polster; Jay Soto; et al. (MobiHealth, 2017)

Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab. - Kirsten I. Taylor; Florian Lipsmeier; Marzia Antonella Scelsi; Ekaterina Volkova-Volkmar; Daria Rukina; Werner Popp; Stefan Lambrecht; Judith Anzures-Cabrera; David Summers; Markus Abt; Annabelle Monnet; Timothy Kilchenmann; et al. (npj Digit. Medicine, 2025)